(Q31943350)

5 July 2017

title

Therapeutic drug monitoring of doxorubicin in paediatric oncology using capillary electrophoresis (English)

1 reference

capillary electrophoresis

5 July 2017

main subject

0 references

0 references

1 reference

Hempel G

1

1 reference

5 July 2017

Schulze-Westhoff P

2

1 reference

5 July 2017

Flege S

3

1 reference

5 July 2017

Laubrock N

4

1 reference

5 July 2017

Boos J

5

1 reference

5 July 2017

publication date

1 November 1998

1 reference

5 July 2017

1 reference

5 July 2017

volume

19

1 reference

5 July 2017

issue

16-17

1 reference

5 July 2017

page(s)

2939-2943

1 reference

describes a project that uses

5 July 2017

capillary electrophoresis

1 reference

Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

Anthracyclines in the treatment of cancer. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Anthracycline antibiotics in cancer therapy. Focus on drug resistance

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Anthracycline-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Liquid chromatography in anticancer drug research with special reference to anthraquinone glycosides

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

High-performance liquid chromatographic determination of doxorubicin and its metabolites in plasma and tissue

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

A sensitive and reproducible HPLC assay for doxorubicin and pirarubicin

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

High-performance liquid chromatographic bioanalysis of anthracycline cytostatic drugs

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

HPLC determination of doxorubicin, doxorubicinol and four aglycone metabolites in plasma of AIDS patients

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Bioanalysis of some anthracyclines in human plasma by capillary electrophoresis with laser-induced fluorescence detection

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Determination of idarubicin and idarubicinol in plasma by capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Analysis of a New Doxorubicin Derivative (FCE 23762) and Related Compounds by High Performance Capillary Electrophoresis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Comparative activity of anthracycline 13-dihydrometabolites against rat glioblastoma cells in culture.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Sequential chemotherapy in good-prognosis patients with small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Pharmacokinetic study of i.v. infusions of adriamycin

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Therapeutic drug monitoring opportunities in cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Pharmacokinetics of anthracyclines

1 reference

https://api.crossref.org/works/10.1002%2FELPS.1150191624

7 January 2021

Identifiers

DOI

10.1002/ELPS.1150191624

1 reference

5 July 2017

1 reference